Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nureca Limited (NSE: NURECA), ISIN INE0DSF01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NURECA last traded at ₹339.80 (-0.12%), with a 52-week range of ₹200.10 to ₹358.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 68.09%, FIIs 0.11%, DIIs 0.24%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.